Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Claudia Sentanin (SAO CARLOS/SP, Brazil). Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis?. 2514

Member's Comments

No comment yet.

Related content which might interest you: Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 Is clinical presentation different between men and women with COPD? Source: International Congress 2014 – Clinical presentations Year: 2014 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Long-term outcome following first clinically important deterioration in COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients? Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Can we personalize COPD treatment by exacerbation frequency and severity? Three years of follow-up Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Pneumonia in exacerbations of COPD: what is the clinical significance? Source: ERJ Open Res, 6 (1) 00282-2019; 10.1183/23120541.00282-2019 Year: 2020 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Clinical and functional effectiveness of roflumilast in severe COPD patients Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 A typical COPD exacerbation? Source: Breathe 2008; 4: 346-354 Year: 2008